MilliporeSigma, Samsung BioLogics Extend Biomanufacturing Strategic Alliance

By Akia Thorpe -

November 15, 2017

MilliporeSigma has signed a Memorandum of Understanding (MoU) with Samsung BioLogics, an Incheon, Korea-based contract biologics manufacturer, for biopharmaceutical manufacturing and biologics process development.

The companies plan to accelerate process development and clinical-material production at small biotechnology start-ups for which Samsung BioLogics acts as a contract manufacturer. Under the agreement, MilliporeSigma would provide process development and support technical training, in addition to providing its proprietary single-use systems to Samsung BioLogics.

The new MoU is an extension of a MoU signed in 2014 that encompasses a long-term supply agreement under which MilliporeSigma provides raw materials for biopharmaceutical manufacturing.

Source: MilliporeSigma